Shares Of Regeneron And Esperion Are Down Today On Cholesterol Panel Vote
June 10, 2015 at 12:04 PM EDT
Shares of Regeneron and Esperion are down after panel recommends approval for new class of Cholesterol drugs but requires larger studies to approve for bigger patient population.
